Analyst Information


Matt O'Brien

Sr. Research Analyst

Matt O'Brien

 Matt O'Brien is a senior research analyst and managing director at Piper Sandler covering medical technology and devices. Before joining Piper in 2014, O'Brien covered medical technology at William Blair for 10 years. Additional work experience includes five years of middle-market investment banking financial advisory work and two years at a healthcare manufacturing and distribution company. O'Brien holds an MBA from the University of Chicago Booth School of Management and a BS in Finance from DePaul University.

Universe Coverage:
Healthcare:   Medical Technology and Devices
ATECAlphatec Holdings, Inc.
APYXApyx Medical Corporation
ATRCAtriCure, Inc.
RCELAVITA Medical, Inc.
AZYOAziyo Biologics, Inc.
BAXBaxter International Inc.
BSXBoston Scientific Corporation
CNMDCONMED Corporation
CUTRCutera, Inc.
DXCMDexCom, Inc.
GKOSGlaukos Corporation
GMEDGlobus Medical, Inc.
HUMAHumacyte, Inc.
PODDInsulet Corporation
IARTIntegra LifeSciences Holdings Corporation
ITMRItamar Medical Ltd.
MDTMedtronic plc
MMSIMerit Medical Systems, Inc.
UTRSMinerva Surgical, Inc.
MOTSMotus GI Holdings, Inc.
STIMNeuronetics, Inc.
NUVANuVasive, Inc.
KIDSOrthoPediatrics Corp.
FNAParagon 28, Inc.
KRMDRepro-Med Systems, Inc.
SPNESeaSpine Holdings Corporation
SGHTSight Sciences, Inc.
SYKStryker Corporation
SRGASurgalign Holdings, Inc.
TCMDTactile Systems Technology, Inc.
TNDMTandem Diabetes Care, Inc.
TFXTeleflex Incorporated
SKINThe Beauty Health Co.
ZBHZimmer Biomet Holdings, Inc.
ZYXIZynex, Inc.